Approval · Notice of Compliance 8057 · 2006
HUMIRA: Notice of Compliance 8057
Issued June 20, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8057
- Date
- June 20, 2006
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Extension of indication: to treat recently diagnosed patients with moderately to severely active rheumatoid arthritis who have not been previously treated with methotrexate
- Therapeutic class
- Biological response modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HUMIRA | Not yet assigned | — |
Medicinal ingredients
- ADALIMUMAB 40 MG per 0.8ML